Back to search

Article

Endophenotype-based polygenic risk scores: Prediction of biomarker and clinical progression and dementia

2022-09-28

Abstract excerpt

<title>Abstract</title> <p>BACKGROUND: Biomarkers provide a framework for a biological diagnosis of Alzheimer’s disease (AD) whereas polygenic risk scores (PRS) provide method to estimate genetic risk. We derive biomarker-based PRS by incorporating endophenotype genetic risk relevant to amyloid, tau, neurodegeneration and cerebrovascular (A/T/N/V) pathology. METHODS: Endophenotype-PRSs (PRS<sub>A</sub>, PRS<sub>T...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b0c1f450-e737-5644-b002-5eea7d5af733
DOI
10.21203/rs.3.rs-2092941/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Endophenotype-based polygenic risk scores: Prediction of biomarker and clinical progression and dementiaDOI 10.21203/rs.3.rs-2092941/v1
Select a neighboring publication to make it the new centre.